RFK Jr. ally says new glyphosate study 'backs EPA into a corner'
A new Nebraska study finds no overall statistical link between county-level glyphosate use and non-Hodgkin lymphoma rates, while federal scientists flag new cancer concerns and an RFK Jr. ally says the research pressures EPA.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers from the University of Nebraska Medical Center published a county-level ecological study on Nov. 11, 2026, in Frontiers in Public Health examining all 93 Nebraska counties from 1987 to 2014. DTN Progressive Farmer reported the study concluded "there was no statistically significant association between mean annual glyphosate application and overall age-adjusted NHL incidence." Glyphosate use in Nebraska soared beginning in the mid-1990s through the late 2000s, with corn accounting for 55% to 60% of estimated use and soybeans 35% to 40%, coinciding with adoption of glyphosate-tolerant crops. Higher glyphosate use appeared in eastern, southeastern and parts of south-central Nebraska where higher NHL incidence also appeared in several counties, but researchers found counties where the pattern diverged, with some showing higher glyphosate use and lower NHL incidence. The study stated: "Consequently, the geographic correspondence observed between glyphosate application and NHL incidence should not be interpreted as evidence of statistically significant spatial associations or causal relationships." The paper referenced the Agricultural Health Study, which the study called "the gold standard for glyphosate use studies because it studied pesticide-use histories for actual applicators," noting its 2018 analysis did not find a statistically significant association between glyphosate use and NHL overall. The Nebraska researchers acknowledged limitations: "County-level glyphosate application does not reflect individual exposure, occupational history, or specific exposure pathways and the observed associations cannot establish causality." They also noted inability to separate glyphosate from other factors: "Potential confounding by other pesticides, agricultural practices, demographic characteristics and socioeconomic factors could not be adequately addressed." The study called for "future investigations incorporating individual-level exposure assessment, relevant co-exposures, and appropriate adjustment for potential confounders." Meanwhile, The Washington Post reported federal scientists have flagged new cancer concerns with the common herbicide. Politico reported an RFK Jr. ally said the new glyphosate study "backs EPA into a corner." POLITICO Pro's E&E News reported EPA shuns labels linking herbicide and cancer. In September, EPA and the Department of Health and Human Services announced a plan to expand information for an updated glyphosate risk assessment expected to be completed next year, with EPA saying it will "systematically evaluate" relevant peer-reviewed research published since its previous assessment and address exposure to glyphosate-based formulations, dietary exposure including from preharvest applications, occupational exposure, and cancer, genotoxicity, reproductive and developmental evidence.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
What did the Nebraska study find about glyphosate and non-Hodgkin lymphoma?
The study found no statistically significant association between mean annual glyphosate application and overall age-adjusted non-Hodgkin lymphoma incidence across Nebraska's 93 counties from 1987 to 2014.
What are the limitations of the Nebraska study?
The study used county-level application data rather than individual exposure measurements, could not separate glyphosate from other pesticides and agricultural practices, and could not establish causality. Researchers called for future studies with individual-level exposure assessment.
What is EPA doing regarding glyphosate risk assessment?
EPA and HHS announced in September a plan to expand information for an updated glyphosate risk assessment expected to be completed next year. EPA will systematically evaluate peer-reviewed research published since its previous assessment and address exposure to glyphosate-based formulations, dietary exposure, occupational exposure, and cancer, genotoxicity, reproductive and developmental evidence.
Coverage (7)
- New study finds no link between glyphosate and non-Hodgkin’s lymphoma Canadian Cattlemen · 6h ago
- E&E News: EPA shuns labels linking herbicide and cancer POLITICO Pro · 6h ago
- Nebraska Study Finds No Overall Link Between County Glyphosate Application, Non-Hodgkin Lymphoma Rates DTN Progressive Farmer · 6h ago
- Increased use of glyphosate doesn’t increase risk of cancer: study The Western Producer · 6h ago
- Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma Genetic Literacy Project · 6h ago
- Federal scientists flag new cancer concerns with common herbicide The Washington Post · 6h ago
- RFK Jr. ally says new glyphosate study 'backs EPA into a corner' Politico · 6h ago
Topics
Related trends
Court approves $7.25 billion settlement with Bayer over claims Roundup weedkiller caused cancer
A Missouri judge approved Bayer's $7.25 billion settlement to resolve thousands of U.S. lawsuits claiming its Roundup weedkiller causes cancer.
See how data centers are changing the American landscape
Expanding data center infrastructure is sparking widespread concerns over public health, environmental degradation, and wildlife protection across the US.
Federal judge restores $7B Solar for All program, says EPA illegally axed it
A federal judge has restored the seven billion dollar Solar for All program, ruling the EPA's cancellation unlawful.
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
Roivant Sciences stock surges as its experimental inhaled lung disease drug hits mid-stage study goals.
Trump lifts summer gasoline restrictions early as prices remain stubborn
The EPA issues emergency gasoline waivers as the national pump average hits $4.10 and prices remain stubborn.
New Type of Blood Thinner Approved to Prevent Repeat Strokes
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.